When patients hear "filler," they usually picture something like Juvéderm or Restylane — a hyaluronic acid gel that adds volume immediately, dissolves gradually over time, and can be reversed with an injection of hyaluronidase if there's a problem. That mental model is accurate for hyaluronic acid fillers, which make up most of the injectable filler market.
It is not accurate for biostimulators. Sculptra and Radiesse — the two most common biostimulator products — work differently, produce results on a different timeline, and importantly, cannot be reversed with hyaluronidase. Treating them as if they're just "another kind of filler" has been the setup for a specific and recurring pattern of complications and dissatisfied outcomes.
This is a plain-language guide to how biostimulators actually work, where they're the right choice, and what patients should understand before agreeing to them.
The two categories of injectable filler
Hyaluronic acid (HA) fillers — Juvéderm, Restylane, Belotero, and RHA products — are gels that add volume immediately at the injection site. They gradually break down over 6–18 months depending on the specific product and location. They can be dissolved on demand with an injection of hyaluronidase, an enzyme that breaks down hyaluronic acid within hours. This reversibility is the single most important safety feature in HA fillers.
Biostimulators — Sculptra (poly-L-lactic acid, or PLLA) and Radiesse (calcium hydroxylapatite, or CaHA) — work fundamentally differently. Instead of adding volume through the injected material, they trigger the body's own collagen production. The injected material serves as a scaffold that the body responds to; the collagen produced over the following weeks and months provides the volume. Both products are gradually absorbed while the collagen response persists.
Biostimulators do not have a comparable enzymatic reversal. Once injected, they remain in place until the body absorbs them (Sculptra typically over 18-24 months, Radiesse over 12-18 months). Complications from over-injection, nodules, or unwanted volume have to be managed with time, steroids, extraction, or other interventions — not a single dissolving injection.
How Sculptra works
Sculptra's active ingredient is poly-L-lactic acid (PLLA), the same material used in dissolvable surgical sutures. It's reconstituted before injection into a suspension that's placed in the deep dermis or subcutaneous tissue.
The immediate effect after injection is a small volume increase from the reconstitution fluid, which resolves within 24–48 hours. The actual result — the collagen response — develops over the following 8–24 weeks. Sculptra treatment is typically delivered in a series of 2–4 sessions spaced 4–8 weeks apart, with final results assessed at 4–6 months after the last session.
Where Sculptra typically fits:
•Full-face volume loss from aging
•Temple hollowing
•Mid-face volume restoration
•Body treatments (buttock augmentation via injection, décolletage)
•Patients seeking gradual, natural-looking volume restoration rather than immediate change
Where Sculptra typically doesn't fit:
•Lip augmentation (biostimulators are generally not used in lips)
•Areas where precise sculpting is required (fine tear-trough correction, precise cheek contouring)
•Patients wanting immediately visible results
•Patients with a history of keloid or hypertrophic scarring
•Areas of very thin skin where nodule risk is elevated
How Radiesse works
Radiesse's active ingredient is calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. Because it has an immediate volume component from the gel plus a longer-term collagen stimulation from the CaHA microspheres, Radiesse behaves like a hybrid — some immediate result, additional collagen-driven result over the following months.
Radiesse is denser than most HA fillers and is typically used for deeper structural augmentation. It should not generally be used in delicate areas or in the tear trough, where its density and non-reversibility create specific risks.
Where Radiesse typically fits:
•Deep structural augmentation (jawline, chin, deep smile lines)
•Hand rejuvenation (an on-label FDA-approved use)
•Volume restoration in patients wanting both immediate and progressive results
Where Radiesse typically doesn't fit:
•Tear troughs and under-eye area (density and non-reversibility create significant complication risk)
•Lip augmentation (density, non-reversibility, and long-term collagen response make it inappropriate)
•Patients with high nodule risk
•Areas where precise reversibility is desirable
The reversibility problem
This is the single most important thing patients considering biostimulators need to understand.
With hyaluronic acid fillers, if you don't like the result — too much volume, asymmetry, migration, or in a rare but serious case, vascular occlusion — hyaluronidase can dissolve the product on the same day. Vascular occlusion (filler injected into or compressing a blood vessel, which can lead to tissue death or blindness) is a genuine filler complication that reputable clinics manage with immediate hyaluronidase injection.
With Sculptra and Radiesse, there is no equivalent reversal.
•Too much volume: wait for gradual absorption over 12-24 months
•Nodules or lumps: steroid injections, saline dilution, massage, or surgical extraction
•Asymmetry: correction with additional product or time
•Vascular occlusion: management with steroids and supportive care, but without the immediate reversibility HA fillers offer
This does not mean biostimulators are dangerous — they're FDA-approved, used widely, and produce excellent results in appropriate applications with skilled injectors. It means the injector's skill and product selection matter more with biostimulators than with HA fillers, because mistakes are much harder to correct.
The consultation conversation
Questions worth asking before agreeing to Sculptra or Radiesse:
1. Why is a biostimulator the right choice for me over an HA filler? There should be a specific reason tied to your anatomy and goals.
2. How long have you been using this specific product, and how often do you use it? Biostimulators have a steeper learning curve than HA fillers; you want an injector with established experience.
3. What's your experience with the specific complications that can occur with this product? Nodules, granulomas, and delayed-onset issues.
4. What's your protocol if I develop a nodule or lump 6 months from now? The answer should be specific — steroid injection, saline dilution, ultrasound-guided extraction — not "we'll figure it out."
5. What's the realistic timeline to see final results? Sculptra: 4-6 months. Radiesse: some immediate, additional over 3-4 months.
6. What happens if I don't like the result? Because biostimulators aren't reversible, the honest answer includes some version of "we'll manage it with additional treatment or wait for absorption."
An injector who dismisses these questions, or who describes biostimulators as "just like regular filler," is either inexperienced or deliberately downplaying the differences. Neither is acceptable for a product with the complication profile these carry.
Cost expectations
Both products are priced by vial or syringe. Rough 2026 ranges:
•Sculptra: $700-$1,100 per vial, typically 2-4 vials required over a treatment series ($1,400-$4,400 total)
•Radiesse: $650-$950 per syringe, typically 1-3 syringes depending on treatment area
Prices vary significantly by geography and injector expertise. Prices well below these ranges warrant specific questions about product authenticity and dilution practices; prices at the very high end should be justified by the injector's specific expertise.
Frequently Asked Questions
Can Sculptra or Radiesse be dissolved if I don't like the result?
No. Unlike hyaluronic acid fillers (Juvéderm, Restylane, and others), biostimulator products cannot be reversed with hyaluronidase or any equivalent enzyme. Sculptra is absorbed by the body over approximately 18-24 months; Radiesse over 12-18 months. Complications and unwanted results have to be managed with steroids, saline dilution, extraction, or time — not immediate reversal. This is the single most important difference between biostimulators and HA fillers.
How long do results from Sculptra and Radiesse actually last?
Sculptra results — from the collagen response to the treatment — typically last 2-3 years, sometimes longer. Radiesse's immediate volume component lasts 12-18 months; the collagen-driven component can persist somewhat longer. Individual results vary based on injection technique, product placement, and patient anatomy.
Are biostimulators safer or riskier than hyaluronic acid fillers?
Neither is inherently safer. HA fillers have a critical safety advantage in reversibility — mistakes and complications can be corrected quickly with hyaluronidase. Biostimulators have advantages in longer-lasting, more natural-looking volume restoration for specific applications. The safety profile depends heavily on injector experience, product selection, and appropriate patient matching. In inexperienced hands, biostimulator complications are harder to fix than HA filler complications.
Can biostimulators be used in the lips?
Neither Sculptra nor Radiesse should be used in lips. Both are contraindicated for lip augmentation — Sculptra because of the nodule risk in the mobile lip tissue, Radiesse because of density, non-reversibility, and the collagen response over time. Any injector recommending either product in the lips is operating outside standard practice.
What happens if a nodule develops after Sculptra?
Most Sculptra nodules can be managed with intralesional steroid injection (typically triamcinolone), saline dilution, or aggressive massage. Persistent nodules may require extraction. Prevention matters — proper technique (deep placement, appropriate dilution, and thorough massage after injection) significantly reduces nodule risk, which is why injector experience with the specific product matters.
Looking for an experienced injector with biostimulator expertise? Browse the AestheticSelect provider directory, filtered by treatment specialty.
Looking for a treatments provider?